These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3364936)

  • 1. Inhibition of invasion activity in vitro by a novel class of antitumor agents: silatrane derivatives.
    Grna A; Ledinko N; Fazely F; Darling S; Hogan J
    Anticancer Res; 1988; 8(2):249-53. PubMed ID: 3364936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of novel silatranes on renal cell carcinoma in mice.
    Grna A; Koo PH; Hogan J
    Anticancer Res; 1992; 12(2):565-9. PubMed ID: 1580573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [1-Ethoxysilatrane: ulcerostatic effect and its possible mechanisms].
    Kuznetsov IG; Rasulov MM; Akabirov AA; Suslova SK; Voronkov MG
    Vopr Med Khim; 1990; 36(2):24-7. PubMed ID: 2363253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of membranotropic effect of methylethyl(silatrane-1-yl methyl) sulfonium iodide].
    Kuznetsov IG; Rasulov MM; Sorokin MS; Suslova SK; Voronkov MG
    Dokl Akad Nauk SSSR; 1988; 301(5):1235-7. PubMed ID: 2852585
    [No Abstract]   [Full Text] [Related]  

  • 5. [The anticoagulant and antisclerotic effects of isopropoxygermatrane and methylethyl(silatrane-1-ylmethyl)sulfonium iodide].
    Rasulov MM; Kuznetsov IG; Velikaia MV; Kaplan BS; Voronkov MG
    Biull Eksp Biol Med; 1989 Dec; 108(12):692-4. PubMed ID: 2634441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possible mechanisms of anti-ulcer action of silatranes].
    Rasulov MM; Kuznetsov IG; Suslova SK; Velikaia MV; Voronkov MG
    Biull Eksp Biol Med; 1990 Sep; 110(9):249-52. PubMed ID: 2268706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocholesterolemic action of 1-ethoxysilatrane.
    Mehta PP; Ramasarma T; Kurup CK
    Biochim Biophys Acta; 1987 Jul; 920(1):102-4. PubMed ID: 3593753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mechanism of membranotropic action of 1-ethoxysilatrane].
    Rasulov MM; Kuznetsov IG; Belousov AA; Voronkov MG
    Dokl Akad Nauk SSSR; 1989; 306(6):1479-82. PubMed ID: 2553369
    [No Abstract]   [Full Text] [Related]  

  • 9. [Silatranes as stimulators of the development of granulation tissue].
    Mansurova LA; Voronkov MG; Slutskiĭ LI; Dombrovska LE; Bumagina TP
    Biull Eksp Biol Med; 1983 Sep; 96(9):97-9. PubMed ID: 6616068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulant and antiatherosclerotic effects of 1-ethoxysilatrane].
    Rasulov MM; Kuznetsov IG; Velikaia MV; Bartkova LK; Voronkov MG
    Dokl Akad Nauk SSSR; 1990; 310(5):1256-9. PubMed ID: 2354655
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of silatranes in combination with Vishnevskii'n ointment in wound treatment].
    Mansurova LA; Voronkov MG; Slutskiĭ LI; Dombrovska LE; Bumagina TP
    Biull Eksp Biol Med; 1983 Mar; 95(3):100-3. PubMed ID: 6830973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of isopropoxysilatrane and isopropoxygermatrane on connective tissue proliferative and reparative function].
    Mansurova LA; Voronkov MG; Slutskiĭ LI; Bumagina TP; Gar TK
    Dokl Akad Nauk SSSR; 1982; 262(6):1505-6. PubMed ID: 7067613
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of haemorrhage on wound healing and its possible modification by 1-ethoxysilatrane.
    Taylor DE; Cooper GJ; Evans VA; Kenward CE; Lawston IW; Penhallow JE; Whamond JS
    J R Coll Surg Edinb; 1986 Feb; 31(1):13-7. PubMed ID: 2940364
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pilotropic activity of silatranes].
    Voronkov MG; Bakhareva EV; Kuznetsov IG
    Dokl Akad Nauk SSSR; 1982; 262(3):736-9. PubMed ID: 7060453
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and antitumor activity of bicyclo[3.3.1]nonenol derivatives.
    Geirsson JK; Jonsson S; Valgeirsson J
    Bioorg Med Chem; 2004 Nov; 12(21):5563-9. PubMed ID: 15465333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methylethyl(silatran-1-ylmethyl)sulfonium iodide--an inhibitor of the development of experimental atherosclerosis of the aorta].
    Rasulov MM; Kuznetsov IG; Sorokin MS; Voronkov MG
    Dokl Akad Nauk SSSR; 1989; 304(2):474-6. PubMed ID: 2731468
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of a prospective antitumor agent, 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane diperchlorate, on cultured mammalian cells.
    Traganos F; Darzynkiewicz Z; Bueti C; Melamed MR
    Cancer Invest; 1984; 2(1):1-13. PubMed ID: 6584191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the periodontium in prolonged hypodynamia and the use of biphosphanates and silatrane for the purpose of their prevention].
    Volozhin AI; Amel'kina GV
    Patol Fiziol Eksp Ter; 1989; (3):72-5. PubMed ID: 2797906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies into the ECG effects of tedisamil (KC 8857) in rats.
    Howard PG; Abraham S; Courtice ID; Walker MJ
    Proc West Pharmacol Soc; 1989; 32():183. PubMed ID: 2780585
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigations on the mechanism of the hypocholesterolemic action of 1-ethoxysilatrane.
    Mehta PP; Ramasarma T; Kurup CK
    Mol Cell Biochem; 1990 Sep; 97(1):75-85. PubMed ID: 2247048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.